Sign In  |  Register  |  About Pleasanton  |  Contact Us

Pleasanton, CA
September 01, 2020 1:32pm
7-Day Forecast | Traffic

  • Search Hotels in Pleasanton

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Medicine Man Technologies Inc (OP: SHWZ )

0.1100 UNCHANGED
Streaming Delayed Price Updated: 1:10 PM EST, Nov 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,258
Open 0.0100
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.1100
Today's Range 0.0100 - 0.1800
52wk Range 0.0100 - 1.550
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Schwazze's Q3 Preliminary Revenue Slides As Debt Grows, 2023 Financials Face Re-Audit
Via Benzinga
Is Colorado's Cannabis Market Back On Track? A 5% Sales Boost Says Yes
The Colorado Department of Revenue reported 673 cannabis dispensaries by the end of August, with an average revenue of $162,000 per store. 
Via Benzinga
Topics Cannabis
Exposures Cannabis

Performance

YTD
-82.24%
-82.24%
1 Month
N/A
N/A
3 Month
-38.89%
-38.89%
6 Month
-78.54%
-78.54%
1 Year
-81.67%
-81.67%

More News

Read More
Almost Every Major Cannabis Company Could See Positive Cash Flow If 280E Is Removed In 2025
Via Benzinga
Topics Cannabis
Exposures Cannabis
Don't Let Hidden Debt Fool You: How Cannabis Investors Can Tell If They Are Safe
Via Benzinga
Topics Cannabis
Exposures Cannabis
Schwazze Q2 Revenue Up 2% YoY, Net Loss Rises And Debt Remains High
Via Benzinga
Medicine Man Technologies: Q4 Earnings Insights
Via Benzinga
Earnings Outlook For Medicine Man Technologies
Via Benzinga
SHWZ Stock Earnings: Medicine Man Technologies Misses EPS, Beats Revenue for Q2 2024
Via InvestorPlace
Out Of Pocket: Which U.S. Cannabis Company Owes The Most Money In 2024?
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Companies About To Release Earnings Reports, Get Your News Here: Glass House, Schwazze And More
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stocks React To Biden Announcement: Monday's Closing Market Moves
Via Benzinga
Topics Cannabis ETFs
Exposures Cannabis
Cannabis Stocks Surge Then Plummet On News That Biden Is Bowing Out Of 2024 Presidential Race
Via Benzinga
Topics Cannabis
Exposures Cannabis
Schwazze Restructures Its $32M Debt Obligations, Improving Financials To Grow Across Colorado And New Mexico
Via Benzinga
7 Cannabis Stocks to Sell in July Before They Crash & Burn
Via InvestorPlace
Topics Cannabis
Exposures Cannabis
Schwazze Cannabis Co Transitions To OTC Expert Market Due To Delayed Filing
Via Benzinga
Topics Cannabis
Exposures Cannabis
Here's Where To Buy Legal Weed: Nevada's Deep Roots Harvest Has New Owner, Shops In Three States That Just Launched Sales
Via Benzinga
Topics Cannabis
Exposures Cannabis
SHWZ Stock Earnings: Medicine Man Technologies Misses EPS, Beats Revenue for Q1 2024
Via InvestorPlace
Schwazze's Q1 2024 Financial Results: Takes A Hit In Colorado, Overall Cannabis Sales Up By 9%
Via Benzinga
Topics Cannabis
Exposures Cannabis
Who's Who In Cannabis: Latest Executive Changes You Should Know About
Via Benzinga
Marijuana Investors Bet Big On Long-Term Growth Over Short-Term Earnings As Market Value Rises By 39%
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Market's Trading Volume Surges Up 292%, Viridian Capital Highlights Mixed Liquidity
Via Benzinga
Topics Cannabis
Exposures Cannabis
Schwazze Records 8% Revenue Growth In Q4 2023 Amid Competitive Cannabis Retail Landscape (CORRECTED)
Via Benzinga
Topics Cannabis
Exposures Cannabis
SHWZ Stock Earnings: Medicine Man Technologies Misses EPS, Misses Revenue for Q4 2023
Via InvestorPlace
Fast Track Recap: Colorado & Michigan Weed Sales Decline, Virginia Eyes Legal Market, Stock Winners & Losers
Via Benzinga
Topics Cannabis
Exposures Cannabis
Colorado Wants To Simplify Cannabis Regulations, Eliminate Fungus Testing: A 500-Page Rulebook Is Too Long, Lawmakers Say
Via Benzinga
Topics Cannabis Product Recall
Exposures Cannabis Legal Product Safety
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photography by Christophe Tomatis
Copyright © 2010-2020 Pleasanton.com & California Media Partners, LLC. All rights reserved.